I Intuitive Surgical, Inc.
$452.07
| Market Cap | $160.56B |
| P/E Ratio | 57.44 |
| Forward P/E | 39.53 |
| Dividend Yield | — |
| Beta | 1.68 |
| 52W Range | $429.59 - $592.85 |
| # Hedge Funds | 4 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
Hedge Fund Ownership
| Investor 4 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Polen Capital Management Polen Capital Management | 2.04% | $477.22M | 842,618 | Buy |
| Mairs & Power Growth Fund Mairs & Power Inc | 0.34% | $35.27M | 62,277 | Buy |
| Francois Rochon Giverny Capital | 0.01% | $229.00K | 405 | Buy |
| Dodge & Cox Dodge & Cox | 0.00% | $283.00K | 500 | — |
Insider Trading
| Insider Name of the company insider who made the trade 54 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Curet MyriamEVP & Chief Medical Officer | Sale | 105 | $493.95 | $51.86K | 10 Mar 2026 | 10 Mar 2026 |
| Brosius MarkSVP & Chief Mfg and Supply Cha | Sale | 645 | $485.01 | $312.83K | 09 Mar 2026 | 06 Mar 2026 |
| Brosius MarkSVP & Chief Mfg and Supply Cha | Sale | 648 | $490.19 | $317.64K | 06 Mar 2026 | 06 Mar 2026 |
| Brosius MarkSVP & Chief Mfg and Supply Cha | Sale | 648 | $495.20 | $320.89K | 05 Mar 2026 | 05 Mar 2026 |
| Brosius MarkSVP & Chief Mfg and Supply Cha | Sale | 2,362 | $498.68 | $1.18M | 04 Mar 2026 | 05 Mar 2026 |
| Curet MyriamEVP & Chief Medical Officer | Sale | 4,728 | $487.18 | $2.30M | 03 Mar 2026 | 03 Mar 2026 |
| Brosius MarkSVP & Chief Mfg and Supply Cha | Sale | 648 | $488.10 | $316.29K | 03 Mar 2026 | 05 Mar 2026 |
| Widman FredrikVP Corporate Controller | Sale | 118 | $487.18 | $57.49K | 03 Mar 2026 | 03 Mar 2026 |
| Curet MyriamEVP & Chief Medical Officer | Sale | 125 | $492.59 | $61.57K | 02 Mar 2026 | 03 Mar 2026 |
| Widman FredrikVP Corporate Controller | Sale | 249 | $499.71 | $124.43K | 27 Feb 2026 | 03 Mar 2026 |
| Curet MyriamEVP & Chief Medical Officer | Sale | 2,345 | $499.71 | $1.17M | 27 Feb 2026 | 02 Mar 2026 |
| WADORS PATRICIA LSVP Chief Human Resources Offi | Sale | 220 | $499.71 | $109.94K | 27 Feb 2026 | 27 Feb 2026 |
| Curet MyriamEVP & Chief Medical Officer | Sale | 421 | $494.96 | $208.38K | 11 Feb 2026 | 11 Feb 2026 |
| Widman FredrikVP Corporate Controller | Sale | 133 | $494.96 | $65.83K | 11 Feb 2026 | 11 Feb 2026 |
| Curet MyriamEVP & Chief Medical Officer | Sale | 105 | $494.65 | $51.94K | 10 Feb 2026 | 11 Feb 2026 |
| Curet MyriamEVP & Chief Medical Officer | Sale | 126 | $520.02 | $65.52K | 29 Jan 2026 | 30 Jan 2026 |
| Curet MyriamEVP & Chief Medical Officer | Sale | 105 | $532.61 | $55.92K | 27 Jan 2026 | 28 Jan 2026 |
| GUTHART GARY S | Sale | 1,400 | $531.52 | $744.13K | 27 Jan 2026 | 28 Jan 2026 |
| GUTHART GARY S | Sale | 1,400 | $531.53 | $744.14K | 27 Jan 2026 | 28 Jan 2026 |
| Curet MyriamEVP & Chief Medical Officer | Sale | 125 | $532.61 | $66.58K | 27 Jan 2026 | 28 Jan 2026 |
| GUTHART GARY S | Sale | 24,500 | $530.10 | $12.99M | 27 Jan 2026 | 28 Jan 2026 |
| Brosius MarkSee Remarks | Sale | 464 | $548.49 | $254.50K | 15 Dec 2025 | 17 Dec 2025 |
| Brosius MarkSVP & Chief Mfg and Supply Cha | Sale | 4,500 | $547.36 | $2.46M | 12 Dec 2025 | 15 Dec 2025 |
| Curet MyriamEVP & Chief Medical Officer | Sale | 104 | $559.90 | $58.23K | 10 Dec 2025 | 10 Dec 2025 |
| Curet MyriamEVP & Chief Medical Officer | Sale | 125 | $568.99 | $71.12K | 01 Dec 2025 | 02 Dec 2025 |
| GUTHART GARY SExecutive Chair of the Board o | Sale | 22,806 | $570.89 | $13.02M | 01 Dec 2025 | 02 Dec 2025 |
| Gary S GuthartExecutive Chair of the Board o | Sale | 22,806 | $570.89 | $13.02M | 01 Dec 2025 | 02 Dec 2025 |
| Charlton Henry LEVP & Chief Commercial and Mkt | Sale | 4,731 | $580.00 | $2.74M | 12 Nov 2025 | 13 Nov 2025 |
| BARRATT CRAIG H | Sale | 750 | $580.00 | $435.00K | 12 Nov 2025 | 13 Nov 2025 |
| Charlton Henry LEVP & Chief Commercial and Mkt | Sale | 2,901 | $580.00 | $1.68M | 12 Nov 2025 | 13 Nov 2025 |
| Charlton Henry LEVP & Chief Commercial and Mkt | Sale | 2,898 | $580.00 | $1.68M | 12 Nov 2025 | 13 Nov 2025 |
| Charlton Henry LEVP & Chief Commercial and Mkt | Sale | 2,565 | $580.00 | $1.49M | 12 Nov 2025 | 13 Nov 2025 |
| Charlton Henry LEVP & Chief Commercial and Mkt | Sale | 636 | $580.00 | $368.88K | 12 Nov 2025 | 13 Nov 2025 |
| Curet MyriamEVP & Chief Medical Officer | Sale | 105 | $560.00 | $58.80K | 10 Nov 2025 | 12 Nov 2025 |
| Miller Brian EdwardEVP & Chief Digital Officer | Sale | 2,202 | $575.00 | $1.27M | 10 Nov 2025 | 12 Nov 2025 |
| Miller Brian EdwardEVP & Chief Digital Officer | Sale | 1,298 | $575.00 | $746.35K | 10 Nov 2025 | 12 Nov 2025 |
| Widman FredrikVP Corporate Controller | Sale | 159 | $550.00 | $87.45K | 05 Nov 2025 | 06 Nov 2025 |
| Widman FredrikVP Corporate Controller | Sale | 1,908 | $550.00 | $1.05M | 05 Nov 2025 | 06 Nov 2025 |
| Fredrik WidmanVP Corporate Controller | Sale | 1,908 | $550.00 | $1.05M | 05 Nov 2025 | 06 Nov 2025 |
| Fredrik WidmanVP Corporate Controller | Sale | 159 | $550.00 | $87.45K | 05 Nov 2025 | 06 Nov 2025 |
| Curet MyriamEVP & Chief Medical Officer | Sale | 125 | $543.00 | $67.88K | 29 Oct 2025 | 29 Oct 2025 |
| Curet MyriamEVP & Chief Medical Officer | Sale | 1,379 | $548.43 | $756.28K | 28 Oct 2025 | 29 Oct 2025 |
| Curet MyriamEVP & Chief Medical Officer | Sale | 1,153 | $548.43 | $632.33K | 28 Oct 2025 | 29 Oct 2025 |
| Curet MyriamEVP & Chief Medical Officer | Sale | 5,030 | $548.43 | $2.76M | 28 Oct 2025 | 29 Oct 2025 |
| GUTHART GARY SExecutive Chair of the Board o | Sale | 1,400 | $546.18 | $764.66K | 24 Oct 2025 | 27 Oct 2025 |
| GUTHART GARY SExecutive Chair of the Board o | Sale | 1,400 | $546.35 | $764.89K | 24 Oct 2025 | 27 Oct 2025 |
| Rosa David J.Chief Executive Officer (CEO) | Sale | 24,500 | $547.55 | $13.41M | 24 Oct 2025 | 27 Oct 2025 |
| BARRATT CRAIG H | Sale | 2,193 | $548.01 | $1.20M | 24 Oct 2025 | 27 Oct 2025 |
| GUTHART GARY SExecutive Chair of the Board o | Sale | 28,800 | $547.56 | $15.77M | 24 Oct 2025 | 27 Oct 2025 |
| David J. RosaChief Executive Officer (CEO) | Sale | 24,500 | $547.55 | $13.41M | 24 Oct 2025 | 27 Oct 2025 |
| Gary S GuthartExecutive Chair of the Board o | Sale | 1,400 | $546.35 | $764.89K | 24 Oct 2025 | 27 Oct 2025 |
| Gary S GuthartExecutive Chair of the Board o | Sale | 28,800 | $547.56 | $15.77M | 24 Oct 2025 | 27 Oct 2025 |
| Craig H BarrattDirector | Sale | 2,193 | $548.01 | $1.20M | 24 Oct 2025 | 27 Oct 2025 |
| Gary S GuthartExecutive Chair of the Board o | Sale | 1,400 | $546.18 | $764.66K | 24 Oct 2025 | 27 Oct 2025 |
Frequently Asked Questions
What is ISRG stock price today?
Intuitive Surgical, Inc. (ISRG) is currently trading at $452.07. The stock has a 52-week range of $429.59 to $592.85 and a market capitalization of $160.56B.
Is ISRG a good stock to buy in 2026?
Intuitive Surgical, Inc. has a P/E ratio of 57.4 (forward P/E: 39.5), a dividend yield of none, and 1-year performance of -8.6%. 4 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling ISRG stock?
There have been 54 insider transactions for ISRG in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has ISRG stock performed over the past year?
Intuitive Surgical, Inc. (ISRG) has returned -8.6% over the past 12 months. The stock traded between $429.59 and $592.85 during this period, and is currently at $452.07.
Which hedge funds own ISRG (Intuitive Surgical, Inc.)?
4 tracked hedge funds currently hold ISRG in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is ISRG's market cap and valuation?
Intuitive Surgical, Inc. (ISRG) has a market capitalization of $160.56B. The trailing P/E ratio is 57.4 and forward P/E is 39.5. The stock is classified in the Healthcare sector.
What is ISRG's revenue and profitability?
Intuitive Surgical, Inc. reported revenue of $10.06B with net income of $2.86B and a profit margin of 0.28%. The stock has a beta of 1.68.
What sector is ISRG in and who are its biggest institutional holders?
Intuitive Surgical, Inc. (ISRG) operates in the Healthcare sector. It is held by 4 tracked hedge funds. See the ownership table above for the complete list.